Hims & Hers Health, Inc. (HIMS) vs PFIZER INC(PFE)
Side-by-side comparison from SEC filings: latest annual financials, insider activity and institutional ownership.
| Metric | HIMS | PFE |
|---|---|---|
| Sector | Health Care | Health Care |
| Latest fiscal year | FY2025 | FY2025 |
| Revenue | $2.35B | $62.58B |
| Revenue growth (YoY) | ▲ 59.0% | ▼ 1.6% |
| Net income | $128.37M | $7.81B |
| Gross margin | 73.8% | — |
| Diluted EPS | $0.51 | $1.36 |
| Insider net (6 mo) | −1.8M sh · 23 sells · 1 buys | +130.5K sh · 2 sells · 3 buys |
| Institutional owners | 40 | 44 |
| Institutional value held | $6.17B | $61.93B |
| Next earnings (est.) | Around Nov 2, 2026 | Nov 3, 2026 |
Figures from each company's SEC filings (latest reported fiscal year; fiscal calendars may differ). Next-earnings dates are estimates from historical filing patterns.
About Hims & Hers Health, Inc. (HIMS)
Hims & Hers Health, Inc., launched in 2017 and headquartered operations built around a consumer-first digital health platform, connects consumers with licensed healthcare providers for telehealth consultations and prescription and non-prescription products add
About PFIZER INC (PFE)
Pfizer Inc. is a research-based, global biopharmaceutical company incorporated in Delaware in 1942 that applies science and global resources to discover, develop, manufacture, market, sell and distribute biopharmaceutical products worldwide, operating across b
Source: SEC EDGAR.